Nasdaq: LENZ
LENZ Therapeutics insiders
The officers, directors and 10% owners of LENZ Therapeutics, Inc. who hold the most stock, valued at the live LENZ price.
$3.34
LENZ today +$130K (+4.05%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their LENZ stock
- $13.4M
- Market value
- $105M
- Held by ranked insiders
- 12.8%
Insiders by value of LENZ holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Versant Venture Capital VI, L.P. | 10% owner | 2,039,700 | $6.8M | 6.49% | Corporate |
| 2 | Versant Ventures VI GP, L.P. | 10% owner | 1,967,275 | $6.6M | 6.26% | Corporate |
| 3 | Jeffrey P. George | Director | 5,592 | $19K | <0.1% | 10705th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for LENZ Therapeutics; see each profile for the filing.